ascorbic-acid and Vertigo

ascorbic-acid has been researched along with Vertigo* in 4 studies

Trials

2 trial(s) available for ascorbic-acid and Vertigo

Article	Year
Radical scavengers for Ménière's disease after failure of conventional therapy: a pilot study. Acta oto-laryngologica, 2003, Volume: 123, Issue:6 To perform a trial to assess the efficacy of radical scavengers, i.e. rebamipide, vitamin C and glutathione, for the treatment of Ménière's disease (MD).. Rebamipide (300 mg/day), vitamin C (600 mg/day) and/or glutathione (300 mg/day) were given orally for at least 8 weeks to 25 patients with poorly controlled MD.. Of 22 patients, 21 showed marked improvement of vertigo; 12/27 ears showed improvement of hearing disorders; 17/27 ears showed improvement of tinnitus; and 18/25 patients showed improvement of disability.. This study suggests that treatment using radical scavengers has the potential to become an effective new therapy for MD. Topics: Adult; Aged; Alanine; Antioxidants; Ascorbic Acid; Female; Free Radical Scavengers; Glutathione; Hearing Loss; Humans; Male; Meniere Disease; Middle Aged; Pilot Projects; Quinolones; Tinnitus; Treatment Failure; Vertigo	2003
[Test use of dihydrostreptomycin ascorbinate in pulmonary tuberculosis]. Antibiotiki, 1966, Volume: 11, Issue:5 Topics: Adult; Ascorbic Acid; Clinical Trials as Topic; Dihydrostreptomycin Sulfate; Drug Eruptions; Eosinophilia; Female; Headache; Humans; Male; Middle Aged; Streptomycin; Sulfates; Tinnitus; Tuberculosis, Pulmonary; Vertigo	1966

Article

Year

Radical scavengers for Ménière's disease after failure of conventional therapy: a pilot study.

Acta oto-laryngologica, 2003, Volume: 123, Issue:6

To perform a trial to assess the efficacy of radical scavengers, i.e. rebamipide, vitamin C and glutathione, for the treatment of Ménière's disease (MD).. Rebamipide (300 mg/day), vitamin C (600 mg/day) and/or glutathione (300 mg/day) were given orally for at least 8 weeks to 25 patients with poorly controlled MD.. Of 22 patients, 21 showed marked improvement of vertigo; 12/27 ears showed improvement of hearing disorders; 17/27 ears showed improvement of tinnitus; and 18/25 patients showed improvement of disability.. This study suggests that treatment using radical scavengers has the potential to become an effective new therapy for MD.

Topics: Adult; Aged; Alanine; Antioxidants; Ascorbic Acid; Female; Free Radical Scavengers; Glutathione; Hearing Loss; Humans; Male; Meniere Disease; Middle Aged; Pilot Projects; Quinolones; Tinnitus; Treatment Failure; Vertigo

2003

[Test use of dihydrostreptomycin ascorbinate in pulmonary tuberculosis].

Antibiotiki, 1966, Volume: 11, Issue:5

Topics: Adult; Ascorbic Acid; Clinical Trials as Topic; Dihydrostreptomycin Sulfate; Drug Eruptions; Eosinophilia; Female; Headache; Humans; Male; Middle Aged; Streptomycin; Sulfates; Tinnitus; Tuberculosis, Pulmonary; Vertigo

1966

Other Studies

2 other study(ies) available for ascorbic-acid and Vertigo

Article	Year
[Clinical efficacy of a novel hemorheological drug ascovertin in patients with vascular encephalopathy]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2004, Volume: 104, Issue:12 Patients with stages I and II of vascular encephalopathy developing on the background of atherosclerosis were treated with ascovertin during 21 days. Ascovertin is a complex of flavonoid dihydroquercetin and ascorbic acid. The study group included 21 patients aged 45-65 years and a comparison group consisted of 10 age-matched patients un treated with ascovertin. The ascovertin treatment relieved headache, reduced vertigo and fatigability, improved cognitive functions. The reliable diminishing of whole blood viscosity due to improvement of cellular rheology indices (decrease of aggregation and increase of erythrocyte deformability as well as decrease of indices of lipid peroxidation in erythrocyte membrane and blood plasma) was observed in the stydy group but not in the comparison one. Topics: Aged; Antioxidants; Ascorbic Acid; Blood Viscosity; Drug Combinations; Erythrocyte Aggregation; Erythrocyte Deformability; Flavonols; Headache; Hemorheology; Humans; Intracranial Arteriosclerosis; Lipid Peroxidation; Middle Aged; Neuropsychological Tests; Quercetin; Sleep Wake Disorders; Tinnitus; Vertigo	2004
Scurvy vertigo. Gastroenterologia, 1946, Volume: 71, Issue:3 Topics: Ascorbic Acid; Humans; Scurvy; Vertigo	1946

Article

Year

[Clinical efficacy of a novel hemorheological drug ascovertin in patients with vascular encephalopathy].

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 2004, Volume: 104, Issue:12

Patients with stages I and II of vascular encephalopathy developing on the background of atherosclerosis were treated with ascovertin during 21 days. Ascovertin is a complex of flavonoid dihydroquercetin and ascorbic acid. The study group included 21 patients aged 45-65 years and a comparison group consisted of 10 age-matched patients un treated with ascovertin. The ascovertin treatment relieved headache, reduced vertigo and fatigability, improved cognitive functions. The reliable diminishing of whole blood viscosity due to improvement of cellular rheology indices (decrease of aggregation and increase of erythrocyte deformability as well as decrease of indices of lipid peroxidation in erythrocyte membrane and blood plasma) was observed in the stydy group but not in the comparison one.

Topics: Aged; Antioxidants; Ascorbic Acid; Blood Viscosity; Drug Combinations; Erythrocyte Aggregation; Erythrocyte Deformability; Flavonols; Headache; Hemorheology; Humans; Intracranial Arteriosclerosis; Lipid Peroxidation; Middle Aged; Neuropsychological Tests; Quercetin; Sleep Wake Disorders; Tinnitus; Vertigo

2004

Scurvy vertigo.

Gastroenterologia, 1946, Volume: 71, Issue:3

Topics: Ascorbic Acid; Humans; Scurvy; Vertigo

1946